| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.6 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |